Sign up for an investor alert! We will inform you about the planned investment round for investors!
The CARDIOVICE™ system is the result of many years of scientific research and hard work of the Telemedical Innovations team! At Telemedical Innovations, we create with passion for modern, innovative technologies and solutions on a global scale. We have created a dynamic organization and we constantly care for its continuous
development.
At the beginning of 2025, we plan to dynamically increase and expand the scope and scale of our operations by launching serial production and starting foreign distribution. You can participate in our success!
Sign up for our investor alert to be the first to know about our investment round!
About us
- We are passionate about
telemedicine and medical devices,
we operate in the MedTech industry. - We have created an innovative
telemedical system
CARDIOVICE™, consisting of a
mobile ECG recorder, dedicated
equipment and a user-friendly
application – used to perform
professional ECG tests and remote
monitoring of the patient's health. - We have designed a unique in
worldwide scale solution – ECG
Vest, by which the patient can easily
and independently perform the
highest quality ECG tests. - With the CARDIOVICE system,
performing professional ECG has
never been so easy! Using the
system and a dedicated, user-
friendly application installed on their
smartphone, each user can
comfortably and efficiently perform
an ECG test anywhere and anytime!
Contact us!
Ireneusz Plaza CEO & Founder
(earlier, the creator and founder of
Telemedicine Polska S.A., listed on
the Warsaw Stock Exchange, including
the NewConnect market)
The use of the CARDIOVICE system
CARDIOVICE™ is a certified medical device – an innovative and modern telemedical system, by which the patient
can easily perform a professional ECG test on their own from anywhere in the world, and then – print the test results or send it remotely for professional doctor’s analysis. All this is due to our specialist vest, based on modern technology, and a dedicated mobile application installed on a smartphone. smartfonie.
The use of the CARDIOVICE system:
- Resting 12-lead ECG "on demand" the gold standard of diagnostics
- Rapid automatic cardiological diagnostics of atrial fibrillation, cardiac arrhythmias, myocardial
ischemia - Cardiological telemonitoring – long-term medical care
- Cardiological telerehabilitation – hybrid rehabilitation of patients after cardiac incidents
- Telemonitoring of chronic heart failure – daily routine ECG tests
- Diagnostics and monitoring of pneumonia, e.g. COVID-19 (*):
– Every single respiratory infection changes the electrical resistance of the lungs
– Bioimpedance detects fluid in the chest, present in severe cases of COVID-19
– ECG vest with bioimpedance continuously monitors patients in isolation
(*) available since version 2.0
Individual Patients
Medical Facilities
(hospitals, medical networks, clinics, private medical practices, rehabilitation centers)
Healthcare industry
Telemedicine and Telecare Industry
What have we achieved?
- We have successfully completed
the R&D phase, - We have a fully functioning
system and devices, - We have implemented the ISO
13485 system and completed the
certification process for compliance
with the requirements of Directive
93/42 (TÜV Rheinland Certificate). - We have a registered patent (in the
EU) for a multifunctional device
enabling cross-measurement of fluid
levels in the lungs using
bioimpedance and automatic
diagnosis based on algorithms and
artificial intelligence. - We have eager customers and distributors, who declared their
willingness to cooperate after the
start of serial production. The
company is currently organizing and
conducting the pilot tests.
Our plans for the nearest future
- We are ready to launch serial
production and start
commercialization in Poland and
abroad (the company has started
pilot tests with a partner from India –
together, we are forming and
creating a distribution company
responsible for import and sales of
our products in the Indian
subcontinent). - We are preparing to investment
round – The raised capital is
intended to be used to further
develop, launch of production and
distribution.
